Evidence map›Paper›PMID 31723224›Full record

ArticleScientific reports2019

Serotonin 5-HT

Michelle A Land, Holly L Chapman, Brionna D Davis-Reyes, Daniel E Felsing, John A Allen, F Gerard Moeller, Lisa A Elferink, Kathryn A Cunningham, Noelle C Anastasio

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Michelle A LandCenter for Addiction Research, Galveston, TX, USA.
Holly L ChapmanCenter for Addiction Research, Galveston, TX, USA.
Brionna D Davis-ReyesCenter for Addiction Research, Galveston, TX, USA.
Daniel E FelsingCenter for Addiction Research, Galveston, TX, USA.
John A AllenCenter for Addiction Research, Galveston, TX, USA.
F Gerard MoellerCenter for Addiction Research, Galveston, TX, USA.
Lisa A ElferinkCenter for Addiction Research, Galveston, TX, USA.
Kathryn A CunninghamCenter for Addiction Research, Galveston, TX, USA.
Noelle C AnastasioCenter for Addiction Research, Galveston, TX, USA. ncanasta@utmb.edu.
Galveston College · USThe University of Texas Medical Branch at Galveston · USVirginia Commonwealth University · US

Funding

Research Supplement to Promote Diversity in Health Related ResearchUL1TR002649 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2018 to 2022
$19.1M
Translational Addiction Sciences CenterP50DA033935 · NIDA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CUNNINGHAM, KATHRYN A. · 2013 to 2017
$6.7M
Translational Explorations in Substance Use DisordersT32DA007287 · NIDA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Kathryn A. Cunningham, Jonathan Dean Hommel · 1994 to 2026
$4.7M
NCATS NIH HHS UL1 TR002649NIDA NIH HHS P50 DA033935NIDA NIH HHS T32 DA007287
6 · The paper itself

Abstract

A non-synonymous single nucleotide polymorphism of the human serotonin 5-HT

Indexed as

Polymorphism, Single NucleotideCalciumCell MembraneCysteineHumansIn Vitro TechniquesReceptor, Serotonin, 5-HT2CSerineSerotoninSerotonin Receptor AgonistsCalciumCysteineReceptor, Serotonin, 5-HT2CSerineSerotoninSerotonin Receptor Agonists

Identifiers

PMID31723224
PMCPMC6853916
OpenAlexW2987223542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.